Progression-Free Survival (PFS) as a Surrogate Endpoint of Overall Survival (OS) in Patients with Metastatic Renal Cell Carcinoma (mRCC)
      QxMD      Google Scholar   
Citation:
Cancer vol 120 (1)
Year:
2014
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Book Volume:
3
Parents:
691  
Children:
None
Program:
OGC
Primary Committee:
GU
Sec. Committees:
   
Pharmas:
 
Grants:
U01 CA157703, U10 CA031946, U10 CA033601, CA031946, CA033601, CA 155296-1A1, R01 CA155296  
Corr. Author:
 
Authors:
           
Networks:
 
Study
CALGB-90206
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Article